USP Chloroquine Phosphate Assay on Luna 5 µm C18(2) 150 x 4.6 mm - System suitability

USP Chloroquine Phosphate Assay on Luna 5 µm C18(2) 150 x 4.6 mm - System suitability
LC Conditions
Column

Luna 5 µm C18(2) 100 Å, LC Column 150 x 4.6 mm, Ea

Brand

Luna

Part No

00F-4252-E0

Phase Name

C18(2)

Elution Type

Gradient

Mobile Phase

A: A = 0.4% triethylamine in methanol and Buffer (70:30) (Buffer: 1.4 g/L of anhydrous dibasic sodium phosphate in water. Adjust with 10% phosphoric acid to a pH of 3.0)

Gradient Profile

Step No.

Time(min)

%A

%B

1

0

100

2

20

100

Flow Rate

1.00 mL/min

Temperature

26°C

System

Agilent Technologies 1260 Infinity Agilent Technologies 1260 Infinity

Detection

LC/UV (DAD, PDA) @ 260 nm (nanometers) (26°C)

Detection Info
Sample Notes

Sample was at 2 µg/mL

Order Items Used in This Application

Luna 5 µm C18(2) 100 Å, LC Column 150 x 4.6 mm, Ea
00F-4252-E0

Luna 5 µm C18(2) 100 Å, LC Column 150 x 4.6 mm, Ea

View Product

  • 1. Phenol
  • 2. CQ Related Compound G (4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate)
  • 3. CQ Related Compound D (7-Chloro-4-{[4-(ethylamino)-1-methylbutyl] amino} quinoline)
  • 4. Hydroxychloroquine sulfate
  • 5. CQ Related Compound A (4,7-dichloroquinoline)
  • 6. Chloroquine (CQ) phosphate
  • 7. CQ Related Compound E (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate)
-OEChem-06211003142D<br><br> 13 13  0     0  0  0  0  0  0999 V2000<br>    2.8660    1.3450    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0<br>    2.8660    0.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    2.0000   -0.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    3.7320   -0.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    2.0000   -1.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    3.7320   -1.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    2.8660   -1.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0<br>    1.4631    0.1550    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    4.2690    0.1550    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    1.4631   -1.4650    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    4.2690   -1.4650    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    2.8660   -2.2750    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>    3.4030    1.6550    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0<br>  1  2  1  0  0  0  0<br>  1 13  1  0  0  0  0<br>  2  3  2  0  0  0  0<br>  2  4  1  0  0  0  0<br>  3  5  1  0  0  0  0<br>  3  8  1  0  0  0  0<br>  4  6  2  0  0  0  0<br>  4  9  1  0  0  0  0<br>  5  7  2  0  0  0  0<br>  5 10  1  0  0  0  0<br>  6  7  1  0  0  0  0<br>  6 11  1  0  0  0  0<br>  7 12  1  0  0  0  0<br>M  END
Compound Name

Phenol

CID

996

Molecular Formula

C6H6O

Molecular Weight

94

No. Hydrogen Bond Acceptors

1

No. Hydrogen Bond Donors

1

Similar Applications

Reversed Phase

Alternative Column for USP Monograph-227: 4-Aminophenol in Acetaminophen-Containing Drug Products_Sample solution on Kinetex EVO C18, 5 µm 150 x 4.6 mm 100 Å.

Kinetex 5 µm EVO C18 100 Å, LC Column 150 x 4.6 mm, Ea

28424

Reversed Phase

Alternative Column for USP Monograph-227: 4-Aminophenol in Acetaminophen-Containing Drug Products_Six replicate injections of Standard solution on Kinetex EVO C18, 5 µm 150 x 4.6 mm 100 Å.

Kinetex 5 µm EVO C18 100 Å, LC Column 150 x 4.6 mm, Ea

28423

Reversed Phase

Alternative Column for USP Monograph-227: 4-Aminophenol in Acetaminophen-Containing Drug Products_Standard solution on Kinetex EVO C18, 5 µm 150 x 4.6 mm 100 Å.

Kinetex 5 µm EVO C18 100 Å, LC Column 150 x 4.6 mm, Ea

28422

Reversed Phase

Alternative Column for USP Monograph-227: 4-Aminophenol in Acetaminophen-Containing Drug Products_System suitability solution on Kinetex EVO C18, 5 µm 150 x 4.6 mm 100 Å

Kinetex 5 µm EVO C18 100 Å, LC Column 150 x 4.6 mm, Ea

28420

Reversed Phase

Alternative Column for USP Monograph-227: 4-Aminophenol in Acetaminophen-Containing Drug Products_Sample solution on Luna Omega PS C18, 5 µm 150 x 4.6 mm 100 Å.

Luna Omega 5 µm PS C18 100Å, LC Column 150 x 4.6 mm, EA

28418

Reversed Phase

Alternative Column for USP Monograph-227: 4-Aminophenol in Acetaminophen-Containing Drug Products_Six replicate injections of Standard solution on Luna Omega PS C18, 5 µm 150 x 4.6 mm 100 Å.

Luna Omega 5 µm PS C18 100Å, LC Column 150 x 4.6 mm, EA

28417

Reversed Phase

Alternative Column for USP Monograph-227: 4-Aminophenol in Acetaminophen-Containing Drug Products_Standard solution on Luna Omega PS C18, 5 µm 150 x 4.6 mm 100 Å.

Luna Omega 5 µm PS C18 100Å, LC Column 150 x 4.6 mm, EA

28416

Reversed Phase

Alternative Column for USP Monograph-227: 4-Aminophenol in Acetaminophen-Containing Drug Products_Overlayed chromatogram of diluent and System suitability solution on Luna Omega PS C18, 5 µm 150 x 4.6

Luna Omega 5 µm PS C18 100Å, LC Column 150 x 4.6 mm, EA

28415

Reversed Phase

Alternative Column for USP Monograph-227: 4-Aminophenol in Acetaminophen-Containing Drug Products_System suitability solution on Luna Omega PS C18, 5 µm 150 x 4.6 mm 100 Å.

Luna Omega 5 µm PS C18 100Å, LC Column 150 x 4.6 mm, EA

28414

Reference solution E according Pharmeuropa draft on Halo 5 µm C18

25978

Reversed Phase

Reference solution E according Pharmeuropa draft on Kinetex 5 µm C18

Kinetex 5 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

25977

Reference solution D according Pharmeuropa draft on Halo 5 µm C18

25976

Reversed Phase

Reference solution D according Pharmeuropa draft on Kinetex 5 µm C18

Kinetex 5 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

25975

Reversed Phase

Paracetamol Impurity K according Pharmeuropa draft on Kinetex 5 µm C18

Kinetex 5 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

25965

Reversed Phase

Paracetamol plus Impurities A, B, F, and D according Pharmeuropa draft on Kinetex 5 µm C18

Kinetex 5 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

25957

Paracetamol and Impurities A, B, F, and D according Pharmeuropa draft on Halo 5 µm C18

25947

Paracetamol Impurity K according Pharmeuropa draft on Halo 5 µm C18

25945

Reversed Phase

Paracetamol Impurity Profile according Pharmeuropa draft on Kinetex 5 µm C18

Kinetex 5 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

25944

Paracetamol Impurity Profile according Pharmeuropa draft on Halo 5 µm C18

25943

Reversed Phase

USP Chloroquine Phosphate Assay on Kinetex 5 µm C18 150 x 4.6 mm - System Suitability

Kinetex 5 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea

25925

Reversed Phase

USP Chloroquine Phosphate Assay on Luna 5 µm C18(2) 150 x 4.6 mm - System suitability

Luna 5 µm C18(2) 100 Å, LC Column 150 x 4.6 mm, Ea

25923

Improved Performance

Zebon ZB-624PLUS QC Test Mix

Zebron ZB-624plus, GC Cap. Column 30m x 0.32mm x 1.8um, Ea

25001

Reversed Phase

Cold Medications on Luna 3u Polar C18 100x4.6mm

Luna Omega 3 µm Polar C18 100 Å, LC Column 100 x 4.6 mm, Ea

24046

Reversed Phase

Analgesics Mix 9 on Luna Omega 1.6u C18 50x2.1mm

Luna Omega 1.6µm C18 100Å, LC Column 50 x 2.1 mm, EA

23485

Reversed Phase

Phenol Selectivity Luna Omega 1.6u C18 50x2.1mm

Luna Omega 1.6µm C18 100Å, LC Column 50 x 2.1 mm, EA

23434

Reversed Phase

Cold medicine compounds on Kinetex 2.6 µm EVO C18

Kinetex 2.6 µm EVO C18 100 Å, LC Column 100 x 4.6 mm, EA

23036

Reversed Phase

Substituted Phenol Isomers on a Kinetex 2.6 µm F5 150 x 4.6

Kinetex 2.6 µm F5 100 Å, LC Column 150 x 4.6 mm, Ea

22799

Reversed Phase

Caffeine and phenol using Kinetex 5u Biphenyl 50x4.6mm

Kinetex 5 µm Biphenyl 100 Å, LC Column 50 x 4.6 mm, Ea

22158

Reversed Phase

Pharma ABN Test 15 Mix on Waters Acquity UPLC using Kinetex 1.7u C18 100x2.1mm @ 0.60mL/min

Kinetex 1.7 µm C18 100 Å, LC Column 100 x 2.1 mm, Ea

20054

Reversed Phase

Pharma ABN Test 15 Mix on Waters Acquity UPLC using Kinetex 2.6u C18 100x2.1mm @ 0.60mL/min

Kinetex 2.6 µm C18 100 Å, LC Column 100 x 2.1 mm, Ea

20053

Reversed Phase

Pharma ABN Test 15 Mix on Waters Acquity UPLC using Kinetex 2.6 C18 100x2.1mm @ 1.0mL/min

Kinetex 2.6 µm C18 100 Å, LC Column 100 x 2.1 mm, Ea

20050

Reversed Phase

Pharma ABN Test 15 Mix on Un-Optimized Agilent 1100 system using Kinetex 2.6u C18 100x4.6mm

Kinetex 2.6 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea

20049

Reversed Phase

Pharma ABN Test 15 Mix on Optimized Agilent 1100 system using Kinetex 2.6u C18 100x4.6mm

Kinetex 2.6 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea

20048

Reversed Phase

Pharma ABN Test 15 Mix on Kinetex 2.6u C18 50x2.10mm @ 1.45mL/min 5min gradient

Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea

20041

Reversed Phase

Pharma ABN Test 15 Mix on Kinetex 1.7u C18 50x2.10mm @ 1.0mL/min 5min gradient

Kinetex 1.7 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea

20040

Reversed Phase

Pharma ABN Test 15 Mix on Kinetex 2.6u C18 50x2.10mm @ 0.8mL/min 5 ming gradient

Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea

20039

Reversed Phase

Pharmaceutical Mixture on Kinetex 2.6µm C8 50x2.1mm ID

Kinetex 2.6 µm C8 100 Å, LC Column 50 x 2.1 mm, Ea

19476

Reversed Phase

Pharmaceutical Mixture on Kinetex XB-C18

Kinetex 2.6 µm XB-C18 100 Å, LC Column 50 x 2.1 mm, Ea

19475

Reversed Phase

Pharmaceutical Mixture on Kinetex C18

Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea

19474

Gel Permeation Chromatography (GPC)

Phenolic Resins

Phenogel 5 µm 500 Å, LC Column 300 x 7.8 mm, Ea

5429